Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 24Gastrointestinal 19Genitourinary 18Head & Neck 6Other hematologic neoplasm 5Lymphoid 4Breast 3Myeloid 2Gynecologic 2Dermatologic 2Classical hematology 2Plasma cell 1Other neoplasm 1Other 1CNS 1

Conditions

Precancerous Conditions 12Neoplasms 4Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Leukemia 4Preleukemia 3Neoplasms by Histologic Type 3Keratosis, Actinic 3Hematologic Diseases 3Bone Marrow Diseases 3Thrombocythemia, Essential 2Skin Diseases 2Primary Myelofibrosis 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Obesity-Related Malignant Neoplasm 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Biphenotypic, Acute 2Immunoproliferative Disorders 2Immune System Diseases 2Hodgkin Disease 2Graft vs Host Disease 2Endometrial Neoplasms 2Waldenstrom Macroglobulinemia 1Venentoclax 1Uterine Prolapse 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease × Other neoplasm × 90 days × Clear all
NCT07216443 2026-04-15

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Orca Biosystems, Inc.

Phase 2 Recruiting
80 enrolled
MyeloidOther hematologic neoplasmOther neoplasm

Acute Disease, Bone Marrow Diseases, Disease, Graft vs Host Disease, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Myelodysplastic Syndromes, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Precancerous Conditions, Preleukemia, Syndrome, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Disease Attributes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡